Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0327 Transporter Info
Gene Name	SLC38A10
Transporter Name	Putative sodium-coupled neutral amino acid transporter 10
Gene ID	124565
UniProt ID	Q9HBR0

Post-Translational Modification of This DT
Overview of SLC38A10 Modification Sites with Functional and Structural Information
Sequence	M T A A A A S N W G L I T N I V N S I V G V S V L T M P F C F K Q C G I V L G A L L L V F C S W M T H Q S C M F L V K S A S L S K R R T Y A G L A F H A Y G K A G K M L V E T S M I G L M L G T C I A F Y V V I G D L G S N F F A R L F G F Q V G G T F R M F L L F A V S L C I V L P L S L Q R N M M A S I Q S F S A M A L L F Y T V F M F V I V L S S L K H G L F S G Q W L R R V S Y V R W E G V F R C I P I F G M S F A C Q S Q V L P T Y D S L D E P S V K T M S S I F A S S L N V V T T F Y V M V G F F G Y V S F T E A T A G N V L M H F P S N L V T E M L R V G F M M S V A V G F P M M I L P C R Q A L S T L L C E Q Q Q K D G T F A A G G Y M P P L R F K A L T L S V V F G T M V G G I L I P N V E T I L G L T G A T M G S L I C F I C P A L I Y K K I H K N A L S S Q V V L W V G L G V L V V S T V T T L S V S E E V P E D L A E E A P G G R L G E A E G L M K V E A A R L S A Q D P V V A V A E D G R E K P K L P K E R E E L E Q A Q I K G P V D V P G R E D G K E A P E E A Q L D R P G Q G I A V P V G E A H R H E P P V P H D K V V V D E G Q D R E V P E E N K P P S R H A G G K A P G V Q G Q M A P P L P D S E R E K Q E P E Q G E V G K R P G Q A Q A L E E A G D L P E D P Q K V P E A D G Q P A V Q P A K E D L G P G D R G L H P R P Q A V L S E Q Q N G L A V G G G E K A K G G P P P G N A A G D T G Q P A E D S D H G G K P P L P A E K P A P G P G L P P E P R E Q R D V E R A G G N Q A A S Q L E E A G R A E M L D H A V L L Q V I K E Q Q V Q Q K R L L D Q Q E K L L A V I E E Q H K E I H Q Q R Q E D E E D K P R Q V E V H Q E P G A A V P R G Q E A P E G K A R E T V E N L P P L P L D P V L R A P G G R P A P S Q D L N Q R S L E H S E G P V G R D P A G P P D G G P D T E P R A A Q A K L R D G Q K D A A P R A A G T V K E L P K G P E Q V P V P D P A R E A G G P E E R L A E E F P G Q S Q D V T G G S Q D R K K P G K E V A A T G T S I L K E A N W L V A G P G A E T G D P R M K P K Q V S R D L G L A A D L P G G A E G A A A Q P Q A V L R Q P E L R V I S D G E Q G G Q Q G H R L D H G G H L E M R K A R G G D H V P V S H E Q P R G G E D A A V Q E P R Q R P E P E L G L K R A V P G G Q R P D N A K P N R D L K L Q A G S D L R R R R R D L G P H A E G Q L A P R D G V I I G L N P L P D V Q V N D L R G A L D A Q L R Q A A G G A L Q V V H S R Q L R Q A P G P P E E S
PTM type	X-O-glycosylation X-Phosphorylation X-Ubiquitination X: Amino Acid

O-glycosylation
Serine	9 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC38A10			[1]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	429
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at SLC38A10 Serine 429 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC38A10			[1]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	524
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at SLC38A10 Serine 524 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC38A10			[1]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	795
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at SLC38A10 Serine 795 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC38A10			[2] , [3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	802
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at SLC38A10 Serine 802 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC38A10			[1]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	806
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at SLC38A10 Serine 806 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC38A10			[1]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	905
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at SLC38A10 Serine 905 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC38A10			[1]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	965
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at SLC38A10 Serine 965 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC38A10			[1]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	997
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at SLC38A10 Serine 997 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC38A10			[1]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1106
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at SLC38A10 Serine 1106 has the potential to affect its expression or activity.
Threonine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC38A10			[1]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	886
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at SLC38A10 Threonine 886 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC38A10			[1]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	902
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at SLC38A10 Threonine 902 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC38A10			[1]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	904
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at SLC38A10 Threonine 904 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC38A10			[1]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	921
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at SLC38A10 Threonine 921 has the potential to affect its expression or activity.
Phosphorylation
Serine	15 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC38A10			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	7
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC38A10 Serine 7 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC38A10			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	18
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC38A10 Serine 18 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC38A10			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	23
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC38A10 Serine 23 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC38A10			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	88
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC38A10 Serine 88 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC38A10			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	109
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC38A10 Serine 109 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC38A10			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	141
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC38A10 Serine 141 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC38A10			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	171
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC38A10 Serine 171 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC38A10			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	685
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC38A10 Serine 685 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC38A10			[8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	795
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC38A10 Serine 795 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC38A10			[9] , [10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	802
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC38A10 Serine 802 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SLC38A10			[11] , [12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	806
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC38A10 Serine 806 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SLC38A10			[13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	882
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC38A10 Serine 882 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence SLC38A10			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	905
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC38A10 Serine 905 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence SLC38A10			[6] , [9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	965
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC38A10 Serine 965 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence SLC38A10			[6] , [9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	997
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC38A10 Serine 997 has the potential to affect its expression or activity.
Threonine	7 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC38A10			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	2
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC38A10 Threonine 2 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC38A10			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	13
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC38A10 Threonine 13 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC38A10			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	26
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC38A10 Threonine 26 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC38A10			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	87
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC38A10 Threonine 87 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC38A10			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	96
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC38A10 Threonine 96 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC38A10			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	123
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC38A10 Threonine 123 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC38A10			[9] , [10]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	772
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC38A10 Threonine 772 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC38A10			[4]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	101
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC38A10 Tyrosine 101 has the potential to affect its expression or activity.
Ubiquitination
Lysine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC38A10			[14]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	422
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC38A10 Lysine 422 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC38A10			[15]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	505
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC38A10 Lysine 505 has the potential to affect its expression or activity.
Proline	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC38A10			[16]
Role of PTM	Potential impacts
Modified Residue	Proline	Modified Location	340
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC38A10 Proline 340 has the potential to affect its expression or activity.
Serine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC38A10			[16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	429
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC38A10 Serine 429 has the potential to affect its expression or activity.

References
1	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: S38AA_HUMAN)
2	Comparison of the anticancer properties of a novel valproic acid prodrug to leading histone deacetylase inhibitors. J Cell Biochem. 2018 Apr;119(4):3417-3428.
3	Phosphoproteome analysis of human liver tissue by long-gradient nanoflow LC coupled with multiple stage MS analysis. Electrophoresis. 2010 Mar;31(6):1080-9.
4	Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics. Mol Cell Proteomics. 2013 Dec;12(12):3851-73.
5	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
6	A fast sample processing strategy for large-scale profiling of human urine phosphoproteome by mass spectrometry. Talanta. 2018 Aug 1;185:166-173.
7	Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors. Mol Syst Biol. 2018 Mar 5;14(3):e7858.
8	Reactive Oxygen Species (ROS)-Activated ATM-Dependent Phosphorylation of Cytoplasmic Substrates Identified by Large-Scale Phosphoproteomics Screen. Mol Cell Proteomics. 2016 Mar;15(3):1032-47.
9	UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
10	iTRAQ-based phosphoproteomic analysis reveals host cell's specific responses to Toxoplasma gondii at the phases of invasion and prior to egress. Biochim Biophys Acta Proteins Proteom. 2019 Mar;1867(3):202-212.
11	Phosphoproteome Analysis Reveals Differential Mode of Action of Sorafenib in Wildtype and Mutated FLT3 Acute Myeloid Leukemia (AML) Cells. Mol Cell Proteomics. 2017 Jul;16(7):1365-1376.
12	Phosphoproteome Profiling Reveals Molecular Mechanisms of Growth-Factor-Mediated Kinase Inhibitor Resistance in EGFR-Overexpressing Cancer Cells. J Proteome Res. 2016 Dec 2;15(12):4490-4504.
13	An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62.
14	Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.
15	UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018 Jul;25(7):631-640.
16	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence